SCHEMBL24635602

SCHEMBL24635602

CCNCC(/C=C1\CCc2c[nH]c3cccc1c23)C(=O)N[C@H](C)CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.36
CYP2D6 P10635 6/20 0.36
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 5/20 0.36
MAPT P10636 5/20 0.36
HPGD P15428 4/20 0.36
CYP3A4 P08684 2/20 0.36
ADRA2A P08913 2/20 0.36
DRD2 P14416 2/20 0.36
ADRA2B P18089 2/20 0.36
DRD1 P21728 2/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
DRD3 P35462 2/20 0.36
HTR2B P41595 2/20 0.36
RECQL P46063 2/20 0.36
HTR6 P50406 2/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24635653 0.76 HTR2A (0.39) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL24635743 0.73 HTR2A (0.39) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL24635493 0.70 TACR1 (0.39) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL25042663 0.66 PARP1 (0.41) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL19216639 0.63 PARP1 (0.43) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL13826528 0.62 HSD17B10 (0.47) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL30876125 0.62 HTR2A (0.67) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL30027791 0.62 HTR2A (0.67) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL24635373 0.62 HTR2A (0.67) HSD17B10CYP2D6MEN1KMT2AALDH1A1
SCHEMBL24635620 0.61 HSD17B10 (0.86) HSD17B10CYP2D6MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226408-A1 NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2022-10-27 WO disclosed